Loading…
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
Fingolimod (FTY720) and its phosphorylated form FTY720P are modulators of sphingosine‐1‐phosphate (S1P) receptors, which are G‐protein coupled receptors linked to cell migration and vascular maturation. The efficacy of FTY720 in autoimmune diseases such as multiple sclerosis and its animal models ha...
Saved in:
Published in: | Glia 2007-12, Vol.55 (16), p.1656-1667 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013 |
---|---|
cites | cdi_FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013 |
container_end_page | 1667 |
container_issue | 16 |
container_start_page | 1656 |
container_title | Glia |
container_volume | 55 |
creator | Jung, C. G. Kim, H. J. Miron, V. E. Cook, S. Kennedy, T. E. Foster, C. A. Antel, J. P. Soliven, B. |
description | Fingolimod (FTY720) and its phosphorylated form FTY720P are modulators of sphingosine‐1‐phosphate (S1P) receptors, which are G‐protein coupled receptors linked to cell migration and vascular maturation. The efficacy of FTY720 in autoimmune diseases such as multiple sclerosis and its animal models has been attributed to its inhibition of lymphocyte trafficking to target organs. In this study, we examined the role of S1P receptors in cultured rat oligodendrocytes (OLGs) and OLG progenitor cells (OPCs) using the active phosphorylated form of FTY720. We found that (1) FTY720P improves the survival of neonatal rat OLGs during serum withdrawal, which is associated with the phosphorylation of extracellular signal regulated kinases (ERK1/2) and Akt; (2) FTY720P regulates OPC differentiation into OLGs in a concentration‐dependent manner; and (3) S1P receptors are differentially modulated by platelet‐derived growth factor (PDGF) resulting in downregulation of S1P5 and upregulation of S1P1 in OPCs. In addition, siRNA studies revealed that S1P1 participates in PDGF‐induced OPC mitogenesis. We conclude that S1P1 and S1P5 serve different functions during oligodendroglial development, and possibly during remyelination. © 2007 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/glia.20576 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68342141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20426750</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi0EotvChR-AfOKAlDKOHds5VhVdKq0A8dFysxx7sjJ448VOBP33TdgFbnAajfTMo3deQp4xOGcA9attDPa8hkbJB2TFoNUVY1w-JCvQraiYaNkJOS3lKwCbF_WYnDClldQgV-TL1TS4MaTBRurSUPD7hIPDQlNPP7L3NKPD_Zgy3SU_RbuQNAw025GmGLbJ4-BzWhJEGsOAdovUYYzlCXnU21jw6XGekc9Xrz9dvqk279bXlxebyglZy8p3Tijhgbe-ttJxXkvmtLZOaNtDJ9sWdNO1XiE2TrgOhOsZ7ztvpdYcGD8jLw7efU5z9jKaXShLAjtgmoqRmouaif-DNYhaqgZm8OUBdDmVkrE3-xx2Nt8ZBmYp3Czvml-Fz_Dzo3Xqduj_oseGZ4AdgB8h4t0_VGa9ub74La0ON6GM-PPPjc3fjFRcNeb27drImxu4FbIxH_g9iVua4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20426750</pqid></control><display><type>article</type><title>Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells</title><source>Wiley</source><creator>Jung, C. G. ; Kim, H. J. ; Miron, V. E. ; Cook, S. ; Kennedy, T. E. ; Foster, C. A. ; Antel, J. P. ; Soliven, B.</creator><creatorcontrib>Jung, C. G. ; Kim, H. J. ; Miron, V. E. ; Cook, S. ; Kennedy, T. E. ; Foster, C. A. ; Antel, J. P. ; Soliven, B.</creatorcontrib><description>Fingolimod (FTY720) and its phosphorylated form FTY720P are modulators of sphingosine‐1‐phosphate (S1P) receptors, which are G‐protein coupled receptors linked to cell migration and vascular maturation. The efficacy of FTY720 in autoimmune diseases such as multiple sclerosis and its animal models has been attributed to its inhibition of lymphocyte trafficking to target organs. In this study, we examined the role of S1P receptors in cultured rat oligodendrocytes (OLGs) and OLG progenitor cells (OPCs) using the active phosphorylated form of FTY720. We found that (1) FTY720P improves the survival of neonatal rat OLGs during serum withdrawal, which is associated with the phosphorylation of extracellular signal regulated kinases (ERK1/2) and Akt; (2) FTY720P regulates OPC differentiation into OLGs in a concentration‐dependent manner; and (3) S1P receptors are differentially modulated by platelet‐derived growth factor (PDGF) resulting in downregulation of S1P5 and upregulation of S1P1 in OPCs. In addition, siRNA studies revealed that S1P1 participates in PDGF‐induced OPC mitogenesis. We conclude that S1P1 and S1P5 serve different functions during oligodendroglial development, and possibly during remyelination. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 0894-1491</identifier><identifier>EISSN: 1098-1136</identifier><identifier>DOI: 10.1002/glia.20576</identifier><identifier>PMID: 17876806</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Cell Differentiation - drug effects ; Cell Lineage ; Cell Survival - drug effects ; Cells, Cultured ; Culture Media, Serum-Free - pharmacology ; Dose-Response Relationship, Drug ; Down-Regulation ; FTY720 ; glial cells ; Mitogens - pharmacology ; Mitosis - physiology ; myelination ; oligodendrocytes ; Oligodendroglia - metabolism ; Oligodendroglia - physiology ; Organophosphates - administration & dosage ; Organophosphates - pharmacology ; Osmolar Concentration ; PDGF ; Platelet-Derived Growth Factor - pharmacology ; Rats ; Receptors, Lysosphingolipid - metabolism ; Sphingosine - administration & dosage ; Sphingosine - analogs & derivatives ; Sphingosine - pharmacology ; sphingosine-1-phosphate ; Stem Cells - cytology ; Stem Cells - drug effects ; Stem Cells - metabolism ; Stem Cells - physiology ; Up-Regulation</subject><ispartof>Glia, 2007-12, Vol.55 (16), p.1656-1667</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>(c) 2007 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013</citedby><cites>FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17876806$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jung, C. G.</creatorcontrib><creatorcontrib>Kim, H. J.</creatorcontrib><creatorcontrib>Miron, V. E.</creatorcontrib><creatorcontrib>Cook, S.</creatorcontrib><creatorcontrib>Kennedy, T. E.</creatorcontrib><creatorcontrib>Foster, C. A.</creatorcontrib><creatorcontrib>Antel, J. P.</creatorcontrib><creatorcontrib>Soliven, B.</creatorcontrib><title>Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells</title><title>Glia</title><addtitle>Glia</addtitle><description>Fingolimod (FTY720) and its phosphorylated form FTY720P are modulators of sphingosine‐1‐phosphate (S1P) receptors, which are G‐protein coupled receptors linked to cell migration and vascular maturation. The efficacy of FTY720 in autoimmune diseases such as multiple sclerosis and its animal models has been attributed to its inhibition of lymphocyte trafficking to target organs. In this study, we examined the role of S1P receptors in cultured rat oligodendrocytes (OLGs) and OLG progenitor cells (OPCs) using the active phosphorylated form of FTY720. We found that (1) FTY720P improves the survival of neonatal rat OLGs during serum withdrawal, which is associated with the phosphorylation of extracellular signal regulated kinases (ERK1/2) and Akt; (2) FTY720P regulates OPC differentiation into OLGs in a concentration‐dependent manner; and (3) S1P receptors are differentially modulated by platelet‐derived growth factor (PDGF) resulting in downregulation of S1P5 and upregulation of S1P1 in OPCs. In addition, siRNA studies revealed that S1P1 participates in PDGF‐induced OPC mitogenesis. We conclude that S1P1 and S1P5 serve different functions during oligodendroglial development, and possibly during remyelination. © 2007 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Lineage</subject><subject>Cell Survival - drug effects</subject><subject>Cells, Cultured</subject><subject>Culture Media, Serum-Free - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Down-Regulation</subject><subject>FTY720</subject><subject>glial cells</subject><subject>Mitogens - pharmacology</subject><subject>Mitosis - physiology</subject><subject>myelination</subject><subject>oligodendrocytes</subject><subject>Oligodendroglia - metabolism</subject><subject>Oligodendroglia - physiology</subject><subject>Organophosphates - administration & dosage</subject><subject>Organophosphates - pharmacology</subject><subject>Osmolar Concentration</subject><subject>PDGF</subject><subject>Platelet-Derived Growth Factor - pharmacology</subject><subject>Rats</subject><subject>Receptors, Lysosphingolipid - metabolism</subject><subject>Sphingosine - administration & dosage</subject><subject>Sphingosine - analogs & derivatives</subject><subject>Sphingosine - pharmacology</subject><subject>sphingosine-1-phosphate</subject><subject>Stem Cells - cytology</subject><subject>Stem Cells - drug effects</subject><subject>Stem Cells - metabolism</subject><subject>Stem Cells - physiology</subject><subject>Up-Regulation</subject><issn>0894-1491</issn><issn>1098-1136</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkE1v1DAQhi0EotvChR-AfOKAlDKOHds5VhVdKq0A8dFysxx7sjJ448VOBP33TdgFbnAajfTMo3deQp4xOGcA9attDPa8hkbJB2TFoNUVY1w-JCvQraiYaNkJOS3lKwCbF_WYnDClldQgV-TL1TS4MaTBRurSUPD7hIPDQlNPP7L3NKPD_Zgy3SU_RbuQNAw025GmGLbJ4-BzWhJEGsOAdovUYYzlCXnU21jw6XGekc9Xrz9dvqk279bXlxebyglZy8p3Tijhgbe-ttJxXkvmtLZOaNtDJ9sWdNO1XiE2TrgOhOsZ7ztvpdYcGD8jLw7efU5z9jKaXShLAjtgmoqRmouaif-DNYhaqgZm8OUBdDmVkrE3-xx2Nt8ZBmYp3Czvml-Fz_Dzo3Xqduj_oseGZ4AdgB8h4t0_VGa9ub74La0ON6GM-PPPjc3fjFRcNeb27drImxu4FbIxH_g9iVua4w</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Jung, C. G.</creator><creator>Kim, H. J.</creator><creator>Miron, V. E.</creator><creator>Cook, S.</creator><creator>Kennedy, T. E.</creator><creator>Foster, C. A.</creator><creator>Antel, J. P.</creator><creator>Soliven, B.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells</title><author>Jung, C. G. ; Kim, H. J. ; Miron, V. E. ; Cook, S. ; Kennedy, T. E. ; Foster, C. A. ; Antel, J. P. ; Soliven, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Lineage</topic><topic>Cell Survival - drug effects</topic><topic>Cells, Cultured</topic><topic>Culture Media, Serum-Free - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Down-Regulation</topic><topic>FTY720</topic><topic>glial cells</topic><topic>Mitogens - pharmacology</topic><topic>Mitosis - physiology</topic><topic>myelination</topic><topic>oligodendrocytes</topic><topic>Oligodendroglia - metabolism</topic><topic>Oligodendroglia - physiology</topic><topic>Organophosphates - administration & dosage</topic><topic>Organophosphates - pharmacology</topic><topic>Osmolar Concentration</topic><topic>PDGF</topic><topic>Platelet-Derived Growth Factor - pharmacology</topic><topic>Rats</topic><topic>Receptors, Lysosphingolipid - metabolism</topic><topic>Sphingosine - administration & dosage</topic><topic>Sphingosine - analogs & derivatives</topic><topic>Sphingosine - pharmacology</topic><topic>sphingosine-1-phosphate</topic><topic>Stem Cells - cytology</topic><topic>Stem Cells - drug effects</topic><topic>Stem Cells - metabolism</topic><topic>Stem Cells - physiology</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jung, C. G.</creatorcontrib><creatorcontrib>Kim, H. J.</creatorcontrib><creatorcontrib>Miron, V. E.</creatorcontrib><creatorcontrib>Cook, S.</creatorcontrib><creatorcontrib>Kennedy, T. E.</creatorcontrib><creatorcontrib>Foster, C. A.</creatorcontrib><creatorcontrib>Antel, J. P.</creatorcontrib><creatorcontrib>Soliven, B.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Glia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jung, C. G.</au><au>Kim, H. J.</au><au>Miron, V. E.</au><au>Cook, S.</au><au>Kennedy, T. E.</au><au>Foster, C. A.</au><au>Antel, J. P.</au><au>Soliven, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells</atitle><jtitle>Glia</jtitle><addtitle>Glia</addtitle><date>2007-12</date><risdate>2007</risdate><volume>55</volume><issue>16</issue><spage>1656</spage><epage>1667</epage><pages>1656-1667</pages><issn>0894-1491</issn><eissn>1098-1136</eissn><abstract>Fingolimod (FTY720) and its phosphorylated form FTY720P are modulators of sphingosine‐1‐phosphate (S1P) receptors, which are G‐protein coupled receptors linked to cell migration and vascular maturation. The efficacy of FTY720 in autoimmune diseases such as multiple sclerosis and its animal models has been attributed to its inhibition of lymphocyte trafficking to target organs. In this study, we examined the role of S1P receptors in cultured rat oligodendrocytes (OLGs) and OLG progenitor cells (OPCs) using the active phosphorylated form of FTY720. We found that (1) FTY720P improves the survival of neonatal rat OLGs during serum withdrawal, which is associated with the phosphorylation of extracellular signal regulated kinases (ERK1/2) and Akt; (2) FTY720P regulates OPC differentiation into OLGs in a concentration‐dependent manner; and (3) S1P receptors are differentially modulated by platelet‐derived growth factor (PDGF) resulting in downregulation of S1P5 and upregulation of S1P1 in OPCs. In addition, siRNA studies revealed that S1P1 participates in PDGF‐induced OPC mitogenesis. We conclude that S1P1 and S1P5 serve different functions during oligodendroglial development, and possibly during remyelination. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17876806</pmid><doi>10.1002/glia.20576</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0894-1491 |
ispartof | Glia, 2007-12, Vol.55 (16), p.1656-1667 |
issn | 0894-1491 1098-1136 |
language | eng |
recordid | cdi_proquest_miscellaneous_68342141 |
source | Wiley |
subjects | Animals Cell Differentiation - drug effects Cell Lineage Cell Survival - drug effects Cells, Cultured Culture Media, Serum-Free - pharmacology Dose-Response Relationship, Drug Down-Regulation FTY720 glial cells Mitogens - pharmacology Mitosis - physiology myelination oligodendrocytes Oligodendroglia - metabolism Oligodendroglia - physiology Organophosphates - administration & dosage Organophosphates - pharmacology Osmolar Concentration PDGF Platelet-Derived Growth Factor - pharmacology Rats Receptors, Lysosphingolipid - metabolism Sphingosine - administration & dosage Sphingosine - analogs & derivatives Sphingosine - pharmacology sphingosine-1-phosphate Stem Cells - cytology Stem Cells - drug effects Stem Cells - metabolism Stem Cells - physiology Up-Regulation |
title | Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A35%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20consequences%20of%20S1P%20receptor%20modulation%20in%20rat%20oligodendroglial%20lineage%20cells&rft.jtitle=Glia&rft.au=Jung,%20C.%20G.&rft.date=2007-12&rft.volume=55&rft.issue=16&rft.spage=1656&rft.epage=1667&rft.pages=1656-1667&rft.issn=0894-1491&rft.eissn=1098-1136&rft_id=info:doi/10.1002/glia.20576&rft_dat=%3Cproquest_cross%3E20426750%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4626-dbc474d039d2a6c33261c88ac48af0b699085b9d7ee5c4cb04cf13fbda6883013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20426750&rft_id=info:pmid/17876806&rfr_iscdi=true |